Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Botulinum toxin type A 💬1件: Botulinum toxin type A5件: Botulinum toxin A; Botulinum toxin type A; BTX-A; Incobotulinumtoxina; Onabotulinumtoxina1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 51, 113, 149, 171, 226 💬
2 Bupropion 💬1件: Bupropion2件: Bupropion; Bupropion hydrochloride2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬4件: 8, 21, 96, 171 💬
3 Bupropion hydrobromide 💬1件: Bupropion2件: Bupropion; Bupropion hydrochloride2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬4件: 8, 21, 96, 171 💬
4 Bupropion hydrochloride 💬1件: Bupropion2件: Bupropion; Bupropion hydrochloride2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬4件: 8, 21, 96, 171 💬
5 Celecoxib 💬1件: Celecoxib1件: Celecoxib1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬13件: 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
6 Dexmedetomidine 💬1件: Dexmedetomidine3件: Dexmedetomidina; Dexmedetomidine; Dexmedetomidine hydrochloride3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
7 Dexmedetomidine hydrochloride 💬1件: Dexmedetomidine3件: Dexmedetomidina; Dexmedetomidine; Dexmedetomidine hydrochloride3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
8 Galactose 💬1件: Galactose1件: Galactose--2件: 171, 222 💬
9 Penicillamine 💬1件: Penicillamine1件: Penicillamine--2件: 51, 171 💬
10 Prabotulinumtoxin A 💬1件: Botulinum toxin type A5件: Botulinum toxin A; Botulinum toxin type A; BTX-A; Incobotulinumtoxina; Onabotulinumtoxina1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 51, 113, 149, 171, 226 💬
11 Succimer 💬1件: Succimer1件: Dmsa--1件: 171 💬
12 Trientine hydrochloride 💬1件: Triethylenetetramine2件: Trientine; Trientine tetrahydrochloride--2件: 58, 171 💬
13 Trientine tetrahydrochloride 💬1件: Triethylenetetramine2件: Trientine; Trientine tetrahydrochloride--2件: 58, 171 💬
14 Zinc acetate 💬1件: Zinc acetate2件: Zinc acetate; Zinc acetate dihydrate--2件: 171, 299 💬
15 Zinc gluconate 💬1件: Zinc gluconate1件: Zinc gluconate--1件: 171 💬